We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi, Allergan Units Agree to Pay $100 Million to Settle Antitrust Claims
Sanofi, Allergan Units Agree to Pay $100 Million to Settle Antitrust Claims
Almost a year after Bayer settled pay-for-delay allegations involving its antibiotic Cipro, Ireland-based Allergan and France-based Sanofi units have struck deals to resolve lingering Cipro claims in ongoing class action litigation, agreeing to pony up $100 million.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor